Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00252369
Status:
TERMINATED
Last Update Posted:
2009-04-24
First Post:
2005-11-10
Brief Title:
Treatment of Perianal Crohns Disease Combining Medical and Surgical Treatment
Sponsor:
Sheba Medical Center
Organization:
Sheba Medical Center
Study Overview
Official Title:
Instillation of Fibrin Glue After Induction of Local Conditions Using Infliximab in the Treatment of Perianal Crohns Disease
Status:
TERMINATED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Low accrual rate
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is aimed to assess the hypothesis that instillation of fibrin glue with the induction of local conditions using Infliximab may be useful in the treatment of perianal Crohns disease
Detailed Description:
Patients with perianal fistulae of Crohns disease will be prospectively enrolled and receive 3 doses of Infliximab If reduction of fistula associated discharge of at least 50 will be recorded commercially available fibrin glue will be instilled into the fistula tract using standard surgical techniques The patients will be followed for 6 months for fistula healing and complications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None